Skip to content
Friday 28 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,806.02
+0.12%
DAX
26,503.52
+0.52%
CAC 40
8,401.36
+0.98%
STOXX 50
6,470.70
+0.72%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 29 September 2022 2:53 pm

Capricorn scraps Tullow deal in favour of merger with New Med Energy

By: Nicholas Earl

Add as a preferred source on Google
Another company listed on the London Stock Exchange could be taken private.
Another company listed on the London Stock Exchange could be taken private.

Capricorn Energy (Capricorn) has dramatically ditched its proposed merger with rival Tullow Oil (Tullow), instead reaching an agreement with Israeli gas group New Med Energy (New Med).

The London-listed company revealed it had secured a binding agreement with New Med to “create a MENA (Middle East and North Africa) gas and energy champion and one of the largest upstream energy independents listed in London.”

Earlier this month, Tullow said it was “fully committed” to the $1.4bn merger despite Capricorn seeking alternatives following shareholder opposition to the deal.

Under the terms of the new deal, Capricorn shareholders will receive a cash special dividend worth $620,, equivalent to £1.72 per share

Meanwhile, New Med unit holders will receive 2.34 new Capricorn shares for each of their existing units.

Capricorn shareholders will hold about 10.3 per cent of the combined entity.

New Med unit holders, along with the partnership’s general partner, will hold the rest.

Read more

KKR to Acquire a 50% Stake in a Portfolio of Developed Renewable Assets from TotalEnergies Across Europe

Capricorn’s board of directors believe the new deal is in the best interests of shareholders and intends to recommend they unanimously back the merger at a later shareholder meeting to approve the transaction.

New Med holds a 45.3 per cent working interest in the Leviathan field in the Mediterranean, and the combined group will create a diversified exploration portfolio across Cyprus, Egypt, Israel, UK, Mexico, Mauritania and Suriname.

Simon Thomson, chief executive of Capricorn, argued the transaction “delivers our shareholders a substantial capital return, together with an ongoing stake in a differentiated UK-listed company, shaped for the future of the energy industry”.

The companies expected to retain Capricorn’s FTSE 250 listing on the London Stock Exchange but trade under New Med Energy.

Shares in the company are currently up 4.2 per cent on Thursday afternoon following the announced deal.

They also intend to list on the Tel Aviv Stock Exchange.

Read more

Astrazeneca share price tumbles on $400bn megamerger talks

Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Energy

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • KKR to Acquire a 50% Stake in a Portfolio of Developed Renewable Assets from TotalEnergies Across Europe

    Business Wire
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Quaise Energy Closes $180 Million Series B with $35 Million Investment from Nabors Industries and Strategic Framework to Build World’s First Superhot Geothermal Power Plant

    Business Wire
  • FGE NexantECA Acquires Square Commodities, Accelerating Its Green Molecules Strategy

    Business Wire
  • Competition watchdog clears Paramount Warner Bros acquisition

    Media
    Paramount, Netflix, Warner logos; media giants intensifying streaming competition and strategic industry shifts
  • Britain should back the North Sea if it wants energy security and net zero

    Opinion
    Oil prices have risen as Israel and Iran tensions escalated.
  • Paramount-Warner Bros deal faces ‘sufficient competition’, says CMA

    Media
    Paramount, Netflix, Warner logos; media giants intensifying streaming competition and strategic industry shifts
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook